Smith & Nephew SNATS Inc. (SNN)
NYSE: SNNHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SNN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $12.47B
- P/E (TTM)
- 20.29
- Forward P/E
- 12.57
- EPS (TTM)
- $1.47
- Dividend yield
- 1.33% ($0.397)
- Ex-dividend date
- Oct 2, 2026
- 52-week range
- 26.12 – 37.09
- Day range
- 29.81 – 30.25
- Volume / Avg
- 1.23M / 1.55M
- Beta
- —
- Shares outstanding
- 418.11M
52-week range
SNN stock today
Smith & Nephew SNATS (SNN) closed at $29.83 on Nov 20, essentially unchanged from the prior close, versus the S&P 500's 3.70% decline. Shares are 19.6% below their 52-week high of $37.09, set on Feb 27, 2026 and 14.2% above the 52-week low of $26.12, in the middle of the past year's range. SNN is down 9.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 9.6%.
At 20.3x trailing earnings, Smith & Nephew SNATS trades below the peer-group median of 23.5x. Its forward P/E of 12.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Smith & Nephew SNATS pays an annual dividend of $0.397 per share, a 1.33% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Smith & Nephew SNATS
Company profileSmith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Dr. Deepak S. Nath Ph.D.
- Headquarters
- Watford
- Employees
- 17,000
- Website
- smith-nephew.com
Financial highlights
Full financialsIn fiscal 2025, Smith & Nephew SNATS generated $6.16 billion in revenue, up 6.1% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $625.0 million (+51.7% year over year), for a net margin of 10.1% versus a median of 7.1% in the prior 5 years. Gross margin was 68.0% (down from 69.6%) and operating margin 12.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $6.16B | $5.81B | $5.55B | $5.21B | $5.21B |
| Growth | +6.09% | +4.70% | +6.40% | +0.06% | +14.30% |
| Net income | $625.00M | $412.00M | $263.00M | $223.00M | $524.00M |
| EPS (diluted) | $0.716 | $0.47 | $0.301 | $0.255 | $0.597 |
Analyst forecast
ForecastConsensus (6 analysts)
hold
Avg. price target
$33.19+11.26%
- Strong buy 1
- Buy 0
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Dividends
Dividend history- Annual dividend
- $0.397
- Dividend yield
- 1.33%
- Last payment
- $0.312
- Ex-dividend date
- Oct 2, 2026
SNN news
All SNN news- Smith & Nephew Breaks Below 200-Day Moving Average - Notable for SNNNasdaq
- Smith & Nephew SNATS Q3 Earnings Call HighlightsNasdaq
- Smith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)Seeking Alpha
- Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Q3 2026 Sales/ Trading Statement Call - SlideshowSeeking Alpha
- Smith & Nephew plc Reports Q3 2026 Revenue of $1,551 million and Lowers Full-Year GuidanceNasdaq
- Smith & Nephew plc Reports Q3 2026 Revenue of $1,551 million and Revises Full-Year GuidanceNasdaqSNN, BF.B
- Smith & Nephew Q3 Revenues Rise, Cuts FY26 Outlook; Continues To Explore Options For OrthopaedicsNasdaq
Smith & Nephew SNATS peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ALGNAlign Technology Inc. | 155.17 | -2.82% | $10.94B | vs SNN |
| AITApplied Industrial Technologies Inc. | 274.99 | -4.65% | $10.04B | vs SNN |
| MASMasco Corporation | 82.60 | -0.23% | $15.92B | vs SNN |
| POOLPool Corporation | 208.23 | -0.70% | $7.44B | vs SNN |
| MSAMSA Safety Incorporated | 170.03 | -3.52% | $6.55B | vs SNN |
| ZBHZimmer Biomet Holdings Inc. | 101.10 | -0.36% | $19.13B | vs SNN |
| DOOBRP Inc. Common Subordinate Voting Shares | 61.90 | -1.56% | $4.40B | vs SNN |
| MTRNMaterion Corporation | 182.47 | -10.02% | $3.81B | vs SNN |
Indexes, lists and sector
Smith & Nephew SNATS stock FAQ
What is Smith & Nephew SNATS's stock price today?
SNN last traded at $29.83 as of Nov 20, 4:00 PM EST, up 0.00% on the day. Prices are delayed at least 15 minutes.
Does Smith & Nephew SNATS pay a dividend?
Yes. Smith & Nephew SNATS pays $0.397 per share annually, a 1.33% yield. The most recent dividend of $0.312 had an ex-dividend date of Oct 2, 2026.
What is SNN's P/E ratio?
SNN trades at a trailing P/E ratio of 20.29 and a forward P/E of 12.57, compared with a median of 23.5 for its closest peers.
Who is Smith & Nephew SNATS's CEO?
Dr. Deepak S. Nath Ph.D. is the chief executive officer of Smith & Nephew SNATS Inc., which has about 17,000 employees.
Has SNN ever split its stock?
Yes. The most recent SNN stock split was a 2499-for-1000 split on Oct 15, 2014, one of 2 splits on record.
What is the SNN 52-week high?
The 52-week high for SNN is $37.09 and the 52-week low is $26.12. The stock is currently 19.6% below its high.